Price
No data yet.
Social Signal Score
Revenue
$4.06M+17.01%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Cameron L. Groome
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 100
- Beta
- 0.57
- Country
- CA
- Piotroski score
- 3 / 9 (Weak)
- Altman Z-score
- 1.74
Financials
Revenue
$4.06M+17.0%Net Income
$-807.1K-193.5%EBITDA
$-186.5K-123.5%Free Cash Flow
$-514.9K-615.1%EPS (diluted)
$-0.01-161.2%Shares Outstanding (diluted)
137.57M+59.4%Operating Expenses
$2.85MCash & Debt
$7.16MReturn of Capital
$209.3KQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $18.61M | $-2.25M | $-0.02 |
| 2024 | $25.39M | $3.52M | $0.03 |
| 2023 | $16.51M | $-39.5K | $-0.00 |
| 2022 | $19.08M | $1.79M | $0.01 |
| 2021 | $18.59M | $1.63M | $0.01 |
| 2020 | $10.52M | $-6.23M | $-0.06 |
| 2019 | $13.41M | $31.9K | $0.00 |
| 2018 | $12.51M | $-8.62M | $-0.09 |
| 2017 | $10.19M | $-3.78M | $-0.04 |
| 2016 | $9.52M | $748.4K | $0.01 |
| 2015 | $8.87M | $614.0K | $0.01 |
| 2014 | $8.40M | $169.0K | $0.00 |
| 2013 | $7.57M | $1.4K | $0.00 |
| 2012 | $6.67M | $-2.64M | $-0.04 |
Valuation
MBXBFhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
80+0.00%Social Signal Score
Mentions (3)
- Newsaccessnewswire.com·5h ago·Negative
… Conference Meetings with Growth-Oriented Investors on October 8, 2026 MISSISSAUGA, ON / ACCESS Newswire / October 6, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF) (Microbix® ), a life sciences innovator, manufacturer, and exporter, announces that it will be presenting to investors at the Cantech Investment Conference, organized by Cantech Media and being hosted at the Arcadian Loft, 8th Floor, 401 Bay Street, Toronto, Ontario on October 8, 2026. Microbix's CEO, Cameron Groome, will pre…
View source ↗ - Newsaccessnewswire.com·13d ago·Negative
…t Meetings with Growth-Oriented Investors, September 25 to 27, 2026 MISSISSAUGA, ON / ACCESS Newswire / September 23, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF)(Microbix® ), a life sciences innovator, manufacturer, and exporter, announces that it will be presenting to investors at the Muskoka Capital Event, organized by Capital Event Management Ltd. and being hosted at the JW Marriott Rosseau Muskoka, in Minett, Ontario, September 25 to 27, 2025.
View source ↗ - Newsaccessnewswire.com·27d ago·Negative
…x Test-Makers Product Lines for Support of Leading IVD Manufacturers MISSISSAUGA, ON / ACCESS Newswire / September 9, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF)(Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it has completed formal qualification to become a supplier for five in-vitro diagnostics (IVD) manufacturers ("Dx Test-Makers"). Each of these five Dx Test-Makers are considered to be one of the ten largest such companies by revenues, and Microb…
View source ↗
Earnings
Thu, Dec 17(in 2 months)
Estimates and results for MBXBF via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Congress trades
No disclosed congressional trades in MBXBF.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.